Novel compounds as LRRK2 protein kinase domain inhibitors

MX2026009752APending Publication Date: 2026-10-02NOVOREX INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MX2026009752
Authority / Receiving Office: MX · MX
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-01-17
Filing Date: 2026-08-05
Publication Date: 2026-10-02

Application Information

Patent Timeline

17 Jan 2025

Priority

05 Aug 2026

Application

MX2026009752

02 Oct 2026

Publication

MX2026009752A

IPC: A61K31/519; A61K31/52; A61P25/16; A61P25/28; C07D473/16; C07D473/34; C07D487/04; C07D487/10; C07D491/048; C07D491/107; C07D498/08

CPC: A61K31/519; A61K31/52; A61P25/16; A61P25/28; C07D473/16; C07D473/34; C07D487/10; C07D487/04

Inventors: KIM Da Mi; KIM Eun Ji

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition comprising a novel LRRK2 protein kinase domain inhibitor or a pharmaceutically acceptable salt thereof for preventing or treating diseases mediated by or associated with LRRK2, and a method for treating and preventing diseases using same.

Need to check novelty before this filing date? Find Prior Art